HeartLungTransplant.2014;33:241–251.
40.BlumeED,RosenthalDN,RossanoJW,forthe
PediMACSInvestigators,etal.Outcomesof
childrenimplantedwithventricularassist
devicesintheUnitedStates:firstanalysisofthe
pediatricinteragencyregistryformechanical
circulatorysupport(PediMACS).JHeartLung
Transplant.2016;35(5):578–584.
41.NovitzkyD.Detrimentaleffectsofbraindeathon
thepotentialorgandonor.TransplantProc.
1997;29:3770–3772.
42.KrishnamoorthyV,BorbelyX,Rowhani-Rahbar
A,etal.Cardiacdysfunctionfollowingbrain
deathinchildren:prevalence,normalizationand
transplantation.PediatrCritCareMed.
2015;16(4):e107–e112.
43.ShemieSD,RossH,PagliarelloJ,etal.On
behalfofthepediatricrecommendationsgroup:
organmanagementinCanada:recommendations
oftheforumonmedicalmanagementto
optimizedonororganpotential.CanMedAssoc
J.2006;174:S13–S30.
44.KalogerisT,BainesCP,KrenzM,KorthuisRJ.
Cellbiologyofischemia/reperfusioninjury.Int
RevCellMolBiol.2012;298:229–317.
45.KirkR,DipchandAI,EdwardsLB,etal.The
registryoftheinternationalsocietyforheartand
lungtransplantation:fifteenthpediatricheart
transplantationreport–2012.JHeartLung
Transplant.2012;31(10):1065–1072.
46.HuangJ,TrinkausK,HuddlestonCB,etal.Risk
factorsforprimarygraftfailureafterpediatric
cardiactransplantation:importanceofrecipient
anddonorcharacteristics.JHeartLung
Transplant.2004;23:716–722.
47.FordMA,AlmondCS,GauvreauK,etal.
Associationofgraftischemictimewithsurvival
afterhearttransplantamongchildreninthe
UnitedStates.JHeartLungTransplant.
2011;30(11):1244–1249.
48.ConwayJ,ChinC,KemnaM,etal.Donors’
characteristicsandimpactonoutcomesin
pediatrichearttransplantrecipients.Pediatr
Transplant.2013;17(8):774–781.
49.ArdehaliA,EsmailianF,DengM,etal.Ex-vivo
perfusionofdonorheartsforhumanheart
transplantation(PROCEEDII):aprospective,
open-label,multicentre,randomisednoninferioritytrial.Lancet.2015;385:2577–2584.
50.DhitalKK,IyerA,ConnellanM,etal.Adult
hearttransplantationwithdistantprocurement
andex-vivopreservationofdonorheartsafter
circulatorydeath:acaseseries.Lancet.
2015;385:2585–2591.
51.MacdonaldP.HearttransplantationfromDCD
donors.Transplantation.2017;1;
10.1097/TP.0000000000001829.
52.RazzoukAJ,JohnstonJK,LarsenRL,etal.
Effectofoversizingcardiacallograftson
survivalinpediatricpatientswithcongenital
heartdisease.JHeartLungTransplant.
2005;24:195–199.
53.KananiM,HoskoteA,CarterC,etal.Increasing
donor-recipientweightmismatchinpediatric
orthotopichearttransplantationdoesnot
adverselyaffectoutcome.EurJCardiothorac
Surg.2012;41(2):427–434.
54.TjangYS,StenlundH,TenderichG,etal.Risk
factoranalysisinpediatrichearttransplantation.
JHeartLungTransplant.2008;27(4):408–415.
55.TangL,DuW,DeliusRE,etal.Lowdonor-torecipientweightratiodoesnotnegativelyimpact
survivalofpediatrichearttransplantpatients.
PediatrTransplant.2010;14(6):741–745.
56.TrentoA,CzerLS,BlancheC.Surgical
techniquesforcardiactransplantation.Semin
ThoracCardiovascSurg.1996;8:126–132.
57.DelNidoPJ,BaileyL,KirklinJK.Surgical
techniquesinpediatrichearttransplantation.
CanterCE,KirklinJK.PediatricHeart
Transplantation.Elsevier:Philadelphia;2007.